Atria Wealth Solutions, Inc. Corcept Therapeutics Inc Transaction History

Atria Wealth Solutions, Inc.

  • $8.74 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024
SELL
$22.21 - $34.48 $27,718 - $43,031
-1,248 Reduced 9.01%
12,610 $409,000
Q1 2024

May 13, 2024
BUY
$21.1 - $27.46 $292,403 - $380,540
13,858 New
13,858 $349,000
Q1 2023

Aug 22, 2023
BUY
$19.2 - $24.47 $378,355 - $482,205
19,706 New
19,706 $426,000
Q1 2023

May 10, 2023
BUY
$19.2 - $24.47 $378,355 - $482,205
19,706 New
19,706 $426,000

Others Institutions Holding CORT

# of Institutions
355
Shares Held
86.2M
Call Options Held
1.12M
Put Options Held
667K
View Full List

About CORCEPT THERAPEUTICS INC

CORT Quotes by TradingView
  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $7.17B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Atria Wealth Solutions, Inc. Portfolio

Follow Atria Wealth Solutions, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atria Wealth Solutions, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Atria Wealth Solutions, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email